The plan will offer people 65 and older — and possibly some younger adults — the option of another booster, in case infections surge again soon.The plan will offer people 65 and older — and possibly some younger adults — the option of another booster, in case infections surge again soon.Coronavirus (2019-nCoV), Vaccination and Immunization, Drugs (Pharmaceuticals), Food and Drug Administration, Centers for Disease Control and Prevention, BioNTech SE, Pfizer Inc, Moderna Inc, United States Politics and GovernmentRead More
